Envair announces new partnership with SmartCompounders

Containment specialist’s isolators now available with an integrated compounder solution

Clean air and containment specialist Envair has announced a new partnership with Dutch engineering firm SmartCompounders. The collaboration means Envair will be the only isolator manufacturer in the UK to offer this innovative solution to personalised medication.

Combining the SmartCompounders Chemo automated solution with the Envair CDC F negative pressure isolator can help pharmacy managers quickly and easily increase output per compounding technician to 20-40 final product containers per hour (IV bags, syringes or elastomeric pumps), improving efficiency and reducing medication errors.

Commenting on the partnership, Envair Managing Director Gary Bagshaw said, “With so many clients demanding efficient ways to deliver personalised medicine, we believe the SmartCompounders Chemo integration, which can also connect to prescribing software, is a giant leap forward for hospital pharmacies.”

Founder and CEO of SmartCompounders, Sander van Vreeland, added, “With their established relationships with hospitals throughout the UK, we are delighted to be able to add our solution to Envair’s portfolio, helping to drive efficiency and improve accuracy in pharmacies and compounding centres.”

Smartcompounders Chemo

The SmartCompounders Chemo solution integrated into Envair isolators enables the automated preparation of personalised/dosebanded cytostatic and antibody medication

Find out more by downloading our data sheet here:

Envair Info sheet_Smart Compounders_601_A4_digital_FINAL

Envair Technology announces acquisition of fume cupboard specialists TCS

As part of their continuing expansion, Envair Technology has announced the acquisition of Lancashire based fume cupboard manufacturers Total Containment Solutions (TCS) in a deal worth £2 million. The funding, through private equity managers Foresight, takes the total investment in Envair Technology to £8 million.

The growth delivered to date by existing group companies ONFAB and Envair Limited has provided the platform for this next stage of the group’s ambition to become the leading global clean air containment company. Envair Technology now offers an expanded product portfolio to clients in the healthcare, pharmaceutical and laboratory sectors, facilitating faster and more agile drug R&D and manufacture across the globe.

Founded in 2004 and with a similar market-leading reputation for quality engineering and service excellence, TCS shares a common business culture with its new sister companies.

Commenting on the investment, Gary Bagshaw, Envair Limited Managing Director, said:

It is just one year since Envair combined with ONFAB to create Envair Technology. In that time, we have continued to grow and thrive, whilst maintaining our levels of customer service and fully seeing the benefits associated with the integration of the two businesses. This acquisition further widens our product offering and flexibility to respond to client needs and as such we welcome Dave McCabe and the TCS team to Envair Technology and look forward to accelerating our combined growth story.

Dave McCabe, TCS Managing Director, added:

“TCS has gone from strength to strength over 15 very successful years and we’ve established ourselves as the market leader in the fume cupboard market with blue chip customers across pharmaceutical, commercial and education sectors. Joining Envair Technology will bring significant benefits for all shareholders as we combine our expertise across the laboratory containment market. The combination of TCS and Envair Technology will allow us to expand to wider markets and serve customers even betterThroughout the investment process it has been a pleasure to work with the Foresight and the Envair Technology teams.” 

COVID-19 update from Envair

As concern continues to grow around the spread of COVID-19 (Coronavirus), we wanted to take this opportunity to update you on the steps we are taking to maintain business continuity.

Our primary concern is the safety of our employees, whilst continuing to provide our usual client services without disruption. Envair Limited remains fully operational both in terms of manufacturing and site based planned preventative maintenance, call outs and repairs.

We will carry on providing our full services until Government advice changes.

Many of our staff are able to work from home and will remain contactable as usual by email, phone or Skype. All field service engineers are continuing to support our clients at their sites, whilst taking every care to stay safe. For those in our manufacturing team, extra safety precautions have been put in place around the building.
Additional care will be taken when cleaning all products due to leave the premises, at the point of pre-delivery inspection.

We are aware that chances of the virus being spread after the initial 72 hours is significantly low, but remain vigilant to the possibility of this varying under different conditions such as temperature or humidity. A log will therefore be taken of despatch dates, times and goods receipt in order to advise Public Health England (PHE) of any goods handled within this period of time, should an employee involved in the process become unwell.

Whilst we are fortunate that none of our team have currently tested positive for the virus, if this changes, we will follow guidance from the relevant authorities and continue to monitor the situation daily.

If you have any questions or concerns, please feel free to call our office and in the meantime, I hope you stay safe and well. Thanks also go to our fantastic healthcare professionals working on the front line to help protect us all.

Best wishes

Gary Bagshaw
Managing Director